Company Filing History:
Years Active: 2020
Title: Andrea Loehr: Innovator in Tumor Treatment Biomarkers
Introduction
Andrea Loehr is a prominent inventor based in San Francisco, CA (US). She has made significant contributions to the field of cancer treatment through her innovative research and patent work. Her expertise lies in developing methods that enhance the understanding of tumor responses to therapies.
Latest Patents
Andrea Loehr holds a patent titled "Immunoglobulin expression levels as biomarker for proteasome inhibitor response." This patent outlines methods for treating tumors in subjects and determining appropriate treatment regimens. The methods involve measuring the expression levels of immunoglobulin, FCGR2B, or a combination thereof. These measurements are crucial for assessing the effectiveness of treatments in individual patients. The patent also includes related kits, computer-readable storage media, systems, and methods implemented by processors in computers.
Career Highlights
Andrea is associated with Onyx Therapeutics, Inc., where she continues to advance her research in cancer therapies. Her work has the potential to significantly impact how tumors are treated, leading to more personalized and effective treatment options for patients.
Collaborations
Andrea collaborates with notable colleagues, including Brian Tuch and Jeremiah Degenhardt. These partnerships enhance her research efforts and contribute to the development of innovative solutions in the field of oncology.
Conclusion
Andrea Loehr is a trailblazer in the realm of tumor treatment biomarkers, with her patent work paving the way for advancements in personalized medicine. Her contributions are vital in the ongoing fight against cancer, and her innovative spirit continues to inspire others in the field.